Mohammad Rashidian

We examined the present and future of AI and translational cancer research for @Cancer_Cell - check out superstar @JoYatesResearch below for more on this perspective! @DanaFarberNews

A great collaboration with my friend @JunQiLab. We screened a small molecule library targeting epigenetic regulators curated by Jun’s team using our dual reporter system. The ensuing mechanistic work required innovative chemical and rigorous molecular biology.

Without its international students, Harvard is not Harvard. hrvd.me/IntStudents25t

Just got notice the NIH grant supporting top trainees in my lab working on epigenetic reprogramming to cure diseases that needlessly disable and kill millions of americans a year has been terminated. Pointless and cruel

Watch our exclusive discussion from #iwCART25 with experts @elizabeth_budde, @m_rashidian1, @MichaelDJain, & @MarcoRuella to hear about potential strategies being explored to improve efficacy & minimize toxicity of #CARTCell therapy 💉🩸: 🎥 ow.ly/tHNc50VOtvt #ImmunoOnc

CD45-PET imaging gives a panoramic view of in vivo immune activity bit.ly/3RNlbFY

CD45-PET is a game-changer for basic and translational immunology—finally letting us track immune dynamics in vivo. Its clinical potential is huge: from diagnosing immune-driven diseases to monitoring therapy response in real time. Excited to help unlock more of its potential!

On Lynch Syndrome Awareness Day, we’re spotlighting research on a vaccine designed to train the immune system to detect and eliminate cancer cells before they form. Learn how this could transform cancer prevention for Lynch syndrome patients: bit.ly/3XwfAa6

Another @DanaFarber superstar @m_rashidian1 discussing his innovative work targeting CD45 as a diagnostic and therapeutic target. Very promising for inflammatory disorders and hematological malignancies! Check his CD45-PET @Nature paper here: rdcu.be/d688j

🚨Excited to share our latest work, now out in @NatureBiotech ! We introduce SEED-Selection, a powerful method that enables high-efficiency enrichment of T cells edited at multiple loci in a single step 🧵👇 🔗 nature.com/articles/s4158…

The 4th Transatlantic Exchanges between @GustaveRoussy and @DanaFarber is set for March 19th. Use QR code below to register virtually! Topic: Radioligand therapy in Oncology @barlesi @barlesi @HJacene @KevinHaigisLab #Fizazi @ellenberlin @Medscape @Servier @m_rashidian1…

That airplane was taking figure skaters, coaches and their families home from a national training camp. It was full of talented young people just beginning their lives, moms and dads, brothers and sisters. My heart is sick as a mother. May God bless, comfort, and keep the…

Top 5 advances in medicine this week (🧵) 1. A tool to image inflammation Inflammation happens in a range of diseases - autoimmunity, aging, cancer - but we lack a tool to visualise it This study used CD45, which is expressed by all - and only - immune cells, as a marker of…

More than 40 percent of #postdocs leave academia. Those who landed a coveted faculty position were more likely to have had a highly cited paper, changed their research topic between their #PhD and postdoc, or moved abroad after receiving their doctorate. pnas.org/doi/10.1073/pn……

CD45-PET is a robust, non-invasive tool for imaging inflammation | Nature ⁦@parkerici⁩ nature.com/articles/s4158…

Excited to share our new work in @Nature - check it out! We developed a way to image the immune system using PET. Our goal? To peer into the body and see where inflammation is hiding 🧐 Many thanks to @AliSalehiFarid, @m_rashidian1 & the whole team 🙏🙏 nature.com/articles/s4158…